Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

Journal of the American Academy of Dermatology（2019）

引用 18|浏览81

暂无评分

摘要

The MELPREDICT model functioned well in a global dataset of familial melanoma cases. Adding pancreatic cancer history improved model prediction. GenoMELPREDICT is a simple tool for predicting CDKN2A mutational status among melanoma patients from melanoma-prone families and can aid in counselling these patients towards genetic testing or cancer risk counselling.

查看译文

关键词

CDKN2A,familial melanoma,GenoMEL,GenoMELPREDICT,mutation prediction

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要